This is the authors' abstract. We don't add key points for this paper.
Increased fetal heart rate variability (FHRV) in intrapartum cardiotocographic recording has been variably defined and poorly understood, limiting its clinical utility. Both preclinical (animal) and clinical (human) evidence support that increased FHRV is observed in the early stage of intrapartum fetal hypoxaemia but can also be observed in a subset of fetuses during the preterminal stage of repeated hypoxaemia. This review of available evidence provides data and expert opinion on the pathophysiology of increased FHRV, its clinical significance and a stepwise approach regarding the management of this pattern, and propose recommendations for standardisation of related terminology.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tarvonen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: